Alder's migraine drug meets main goal in late-stage study
June 27 Alder BioPharmaceuticals Inc said on Tuesday its experimental treatment to prevent episodic migraine met the main goal of reducing monthly migraine days in a late-stage study.
Feb 15 Quantel SA :
* Quantel reorganizes its leadership team
* Announces departure of general manager Laurent Schneider-Maunoury Source text for Eikon: Further company coverage: (Gdynia Newsroom)
LONDON, June 27 Uber said it had won the right to appeal against a court decision in favour of plans by a London regulator to impose new English reading and writing standards in a move which could deprive it of thousands of drivers.